Abstract
Sotorasib plus panitumumab for pre-treated non-small cell lung cancer with <i>KRAS</i>G12C mutation: A phase 1b study.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have